Cofactor Genomics, Inc., a clinical-stage company focused on bridging the precision medicine gap through RNA decoding, today announced the validation and launch of OncoPrism®-NSCLC, an RNA-based diagnostic test designed to…
Certinal eSign, a leader in Digital Transaction Management, has strengthened its strategic partnership with Bumrungrad International Hospital, a globally recognized healthcare provider, to revolutionize patient registration and data management. This…
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company focused on using patients’ own biology to treat rare diseases, presented safety data from its Phase 3 ATTeST (Ataxia-Telangiectasia Trial with…
Neurogene Inc. (Nasdaq: NGNE), a clinical-stage biotechnology company focused on developing genetic medicines for rare neurological diseases, today reported positive interim results from the first four participants in the low-dose…
Oncoinvent ASA, a clinical-stage company developing alpha emitter therapies for solid cancers, today reported interim data from the Phase 1/2a trials of Radspherin® for the treatment of peritoneal carcinomatosis. Recruitment…
Tempus AI, Inc. (NASDAQ: TEM), a leader in applying artificial intelligence to drive advancements in precision medicine and patient care, today announced that nine of its abstracts have been accepted…
Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests…
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition…
Key Financial Highlights for Q3 2024: Recent Operating Highlights: CEO Comments: “We had another record quarter, driven by significant reimbursement tailwinds for Guardant360 and strong volume growth,” said Helmy Eltoukhy,…
Inocras Inc. (San Diego, CA; President & CEO: Jehee Suh) and Summit Pharmaceuticals International Corporation (Tokyo, Japan; President & CEO: Katsuya Okuyama) have signed a Memorandum of Understanding (MOU) to…
Anumana, a leading AI-driven health technology company, announced that the Centers for Medicare & Medicaid Services (CMS) has recognized its low ejection fraction (LEF) ECG-AI™ technology in the 2025 Hospital…
ELIQUENT Life Sciences, a global regulatory consulting firm, is pleased to announce the addition of Shelley Gandhi, a renowned pharmacovigilance (PV) expert, to its team. This strategic hire strengthens ELIQUENT’s…